Feasibility study on new test for Prostate Cancer

Oncascan Limited正在开发一种独特的癌症血液检测方法，与现有的筛查和诊断方法结合使用，可以大大提高其整体性能。具体而言，这种改进的性能将导致更少的不必要的侵入性后续程序。这项在诊所进行测试的提议将评估它的表现。采用新的测试可能会带来广泛的多重好处：·对患者（减少干预措施引起的压力，风险或不适）;·对临床医生（提高诊断速度和准确性）;以及·对卫生服务提供者（节省大量成本）。

Oncascan Limited is developing a unique type of blood test for cancer which, used in conjunction with existing methods of screening and diagnosis, could greatly improve their overall performance. Specifically this improved performance would lead to far fewer unnecessary invasive follow up procedures. This proposal to run the test in a clinic will assess how well it might perform. Adopting the new test could result in widespread multiple benefits:• for patients (reduced stress, risk or discomfort arising from interventions);• for clinicians (greater speed and accuracy of diagnosis); and• for health service providers (substantial cost savings).